A new study suggests that the use of biologics in patients with inflammatory skin diseases is safe during the Covid-19 pandemic.
Researchers target skin protein that may be linked to severity of psoriasis
New research has suggested that the levels of interferon kappa, a skin protein, may be linked to the severity of psoriasis.
New research suggests bias in studies detailing risk of Covid-19 in psoriasis and psoriatic arthritis patients
A recent systematic evaluation of studies on the risk of Covid-19 in patients with psoriasis and psoriatic arthritis has suggested a high risk of bias. Specifically, papers linking respiratory infection in psoriasis and psoriatic arthritis patients treated with biological therapies.
HealthMinute.TV 